Chrysler
Summary
NHTSA campaign 24V573: Chrysler recalled for a safety defect. A seat back that is not locked into position can increase the risk of injury in a crash.
Details
Source
nhtsa
External ID
24V573
Action Date
2024-08-01
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2023 Dodge Challenger vehicles. The left rear seat back may not lock in the upright position. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 207, "Seating Systems."
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle